Opportunity Information: Apply for RFA AA 21 004
The NIH funding opportunity titled "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)" (RFA-AA-21-004) is a discretionary research grant program designed to fund rapid, time-sensitive studies on how alcohol use intersects with COVID-19 outcomes and pandemic-related consequences. It uses the R21 mechanism, which is typically aimed at exploratory or developmental research that can move quickly and generate actionable findings, and it explicitly does not allow clinical trials. The core intent is to support projects where waiting for standard NIH review and award timelines would reduce the feasibility of the work or undermine the value of the results, especially if the findings could help inform near-term public health decisions during the active pandemic period.
The scientific focus is centered on two main, tightly connected problem areas. First, the FOA seeks research on whether and how alcohol misuse influences the incidence of SARS-CoV-2 infection and the severity of COVID-19 disease. This can include understanding alcohol-related biological, behavioral, or social pathways that may increase exposure risk, worsen immune response, or contribute to more severe clinical outcomes. Second, it targets research on the reverse direction of influence: how COVID-19 illness itself, along with pandemic-driven mitigation measures (for example, lockdowns, social distancing, job loss, reduced access to in-person care, and broader disruptions), may have changed patterns of alcohol consumption and increased risk for alcohol use disorder (AUD). In practical terms, the FOA is looking for studies that clarify whether pandemic conditions led to increases in drinking, relapse, hazardous use, or barriers to treatment, and how those changes played out across different populations and settings.
A key theme throughout the announcement is urgency and immediate public health relevance. Applications are expected to be time-sensitive in a way that makes accelerated support important, such as capturing rapidly evolving behaviors during a specific phase of the pandemic, leveraging perishable data sources, or evaluating consequences that are most informative while the pandemic context is still unfolding. The goal is not just to produce general knowledge about alcohol and infectious disease, but to generate findings that can directly inform ongoing responses to COVID-19, including prevention messaging, service delivery strategies, and planning for alcohol-related harms linked to pandemic conditions.
Eligibility is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education when applying in that category); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based and community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, there are notable restrictions related to foreign participation. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as applicant organizations, and non-domestic components of U.S. organizations are also not eligible to apply. However, the FOA allows "foreign components" as defined in the NIH Grants Policy Statement, meaning a U.S. applicant may include certain international elements of the project when justified and compliant with NIH policy, even though the primary applicant organization must be domestic.
Administrative details provided in the source data indicate this opportunity is administered by the National Institutes of Health under CFDA 93.273, with an original closing date of August 17, 2021, and a creation date of February 5, 2021. While the excerpt does not list an award ceiling or expected number of awards, the emphasis on time-sensitive, high-impact questions suggests the program was intended to quickly mobilize research capacity to answer pressing questions at the intersection of alcohol use and COVID-19, with results that could be used promptly by public health leaders, healthcare systems, and community organizations.Apply for RFA AA 21 004
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2021-02-05.
- Applicants must submit their applications by 2021-08-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Tobacco Regulatory Science (R01 Clinical Trial Optional)
Previous opportunity: Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AA 21 004
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AA 21 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) Apply for RFA AA 21 003 Funding Number: RFA AA 21 003 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 011 Funding Number: RFA RM 21 011 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 21 060 Funding Number: PAR 21 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 21 125 Funding Number: PAR 21 125 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Human Immunology Project Consortium (U19 Clinical Trial Optional) Apply for RFA AI 20 079 Funding Number: RFA AI 20 079 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) Apply for PA 21 164 Funding Number: PA 21 164 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) Apply for PAR 20 319 Funding Number: PAR 20 319 Agency: National Institutes of Health Category: Health Funding Amount: $15,000,000 |
| Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 006 Funding Number: RFA AI 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 21 002 Funding Number: RFA OD 21 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Frontier Health Markets APS Apply for 7200AA21APS00005 Funding Number: 7200AA21APS00005 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional) Apply for RFA TW 21 003 Funding Number: RFA TW 21 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) Apply for PAR 21 120 Funding Number: PAR 21 120 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 - Clinical Trial Not Allowed) Apply for PAR 21 146 Funding Number: PAR 21 146 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 21 007 Funding Number: RFA AI 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed) Apply for RFA AI 21 022 Funding Number: RFA AI 21 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required) Apply for RFA HL 22 007 Funding Number: RFA HL 22 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed) Apply for PAR 21 147 Funding Number: PAR 21 147 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) Apply for RFA MH 21 120 Funding Number: RFA MH 21 120 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed) Apply for PAR 21 149 Funding Number: PAR 21 149 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed) Apply for RFA HL 22 002 Funding Number: RFA HL 22 002 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AA 21 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
